Switching from Ozempic to Wegovy (or Vice Versa)

Switching between Ozempic and Wegovy is one of the simpler GLP-1 transitions because they're the same drug. The active molecule is identical — only the label, the dose ceiling, and the FDA-approved indication differ. That makes switching mostly a paperwork and pen-strength exercise rather than a clinical event.

Still, there are right and wrong ways to do it. The wrong way produces unnecessary nausea or a gap in dosing. The right way is anticlimactic.

When people actually switch

The most common reasons:

• Insurance change. A new employer plan covers one but not the other.
• Wegovy supply is now reliable. Many patients started on Ozempic during the 2022–2024 Wegovy shortage and now want to move to the on-label brand.
• Off-label Ozempic prescriptions are getting denied. Insurers tightening up.
• Hit a plateau on 2.0 mg Ozempic. Want the extra 0.4 mg headroom Wegovy offers.
• Diagnosis change. A new T2D diagnosis (Ozempic now covered) or a shift in goals to weight loss specifically (Wegovy).
• Cost. Sometimes one is cheaper than the other under a specific plan.

For the underlying differences between the two brands, see Ozempic vs Wegovy.

The core switching principle: same mg, no washout

Because the molecule is identical, you switch at the same milligram dose you were already taking. No washout period, no re-titration — just continue your current dose using the new pen.

*The Wegovy line doesn't include a 2.0 mg pen — you go from 1.7 to 2.4. If you were on 2.0 mg Ozempic and switching to Wegovy with the goal of going higher, the typical path is 1.7 mg Wegovy for 4 weeks (small step down), then 2.4 mg.

Same logic in reverse going Wegovy → Ozempic, except Ozempic stops at 2.0 mg, so a Wegovy 2.4 mg user moving to Ozempic would step down to 2.0 mg.

Mechanics of the switch

Step by step, the actual process:

1. New prescription. You need a fresh prescription for the new brand. Pharmacies can't substitute one for the other.
2. Confirm the pen strength matches your current mg. This trips people up — Wegovy and Ozempic pens come in different strength lineups (see below).
3. Inject the new pen on your normal weekly day. Same site rotation, same technique. See injection sites.
4. Continue weekly as usual.

That's it. No "first week" effects, no settling-in period, no resetting any clock.

Pen strengths: where the actual difference lives

The brand pens have different strength lineups, which can complicate the switch if you're not paying attention.

Ozempic pen strengths:

• 0.25 mg / 0.5 mg pen (delivers 0.25 mg or 0.5 mg per dose)
• 1.0 mg pen
• 2.0 mg pen

Wegovy pen strengths:

• Single-strength pre-filled pens at: 0.25, 0.5, 1.0, 1.7, and 2.4 mg

So an Ozempic 0.5 mg user switching to Wegovy gets a 0.5 mg Wegovy pen. An Ozempic 1.0 mg user gets a 1.0 mg Wegovy pen. The dose stays the same; the hardware changes.

When you might want to re-titrate (or not)

The default is don't re-titrate. You've already done the gut-adaptation work. The drug is identical. Restarting the ramp adds months for no clinical benefit.

The exceptions:

• You've been off the drug for 4+ weeks — see missed dose for the restart logic. Apply it regardless of which brand you're picking up.
• You're switching for a side-effect reason — for example, dropping from 2.4 mg Wegovy to 1.0 mg Ozempic because you couldn't tolerate the higher dose. In that case the new lower dose may need a brief settling period.
• You're switching to a new molecule entirely — for example, semaglutide to tirzepatide. That's a different conversation; see tirzepatide vs semaglutide.

Insurance considerations

This is the most common practical issue:

• Most insurers require a fresh prior authorization for the new brand. If your plan covered Ozempic but you're moving to Wegovy, expect to re-document everything (BMI, comorbidities, prior treatments, etc.).
• Step therapy may apply. Some plans require you to fail metformin, then a cheaper GLP-1, before approving Wegovy specifically.
• Coverage is brand-specific. Even though the drug is identical, formularies treat them as separate products.

The administrative friction can be significant. Patients sometimes find it takes 2–4 weeks to get authorization on the new brand, which means planning the switch around your current pen supply.

What if the new brand isn't ready yet?

If your prescription is approved but the pharmacy can't fill it before your next injection day:

• Use your current brand for one more week if you have it. Same dose. No gap needed.
• If you've run out of the current brand and the new one is still 5+ days late, you'll have a gap. See missed dose for how to handle the resumption.

Switching during titration vs. at maintenance

A mid-titration switch is fine — just continue at the dose step you're on. If you're on week 7 of 0.5 mg and switching brands, you take 0.5 mg of the new brand on your next injection day, and your week-9 dose increase to 1.0 mg happens on schedule.

A maintenance-dose switch is even simpler. Same mg, new pen, no schedule change.

What about Rybelsus?

Rybelsus is the third semaglutide brand, but it's an oral tablet rather than an injection. Switching from Ozempic or Wegovy to Rybelsus (or vice versa) is not a same-mg conversion — Rybelsus has only about 1% bioavailability, so its 14 mg daily tablet roughly corresponds to a much lower injectable dose. That switch always involves a re-titration on the new form.

The injectable-to-injectable switch (Ozempic ↔ Wegovy) is the simple one.

What you'll notice (probably nothing)

Patients who have switched at the same mg dose generally report no detectable difference. Same appetite suppression, same side-effect profile, same weight-loss trajectory. The pens look slightly different, the labels look different, and that's about it.

If you do notice a change after a same-mg switch, it's far more likely to be:

• Coincidence with a normal week-to-week variation
• A counterfeit or mishandled pen — store properly, buy from reputable pharmacies
• Compounded vs. brand differences — a different conversation; see compounded safety

Switching to a different molecule entirely

If your goal is to leave semaglutide for tirzepatide (or another molecule), that's a different procedure with a slightly different protocol. See tirzepatide vs semaglutide for the comparison and switching considerations.

Related questions

• Ozempic vs Wegovy: what's the difference?
• Semaglutide dosing schedule: week by week
• Mounjaro vs Zepbound: same molecule, different brand